HPV-IMMUNTHERAPIE
European patent · EP3743436 · In force
Register entry
- Publication number
- EP3743436
- Application number
- EP19743421
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 23, 2019
- Published
- Dec 2, 2020
- Granted
- Aug 26, 2026
- Protection ends at the latest
- Jan 22, 2039
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 39/12 (2006.01)A61K 35/17 (2025.01)A61K 38/00 (2006.01)A61K 35/15 (2025.01)C07K 16/084 (2026.01)A61K 38/17 (2006.01)A61P 31/20 (2006.01)A61K 39/00 (2006.01)C12N 5/0783 (2010.01)C12N 5/078 (2010.01)C07K 14/005 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201862621279 P 24.01.2018
- PCT application
- PCT/IB2019/000131 23.01.2019
- PCT publication
- WO2019/145792 01.08.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 26, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 26.08.2026
Parties
Inventor
KHANNA, Rajiv
Herston, QLD 4006, AU
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.